Homepage
Catalog of Screening Compounds
Screening Libraries
Focused and Target Libraries
Active Reference Sets
Diversity Libraries
Screening Compounds
Building blocks
Drug Discovery Services
Custom Chemistry
Medicinal chemistry
In silico Drug Design (CADD)
Discovery Biology
Animal Models
Toxicology and Safety
ADME, DMPK
Chemistry, Manufacturing and Controls
Company
News & Media
Contact us
For suppliers
Trends in discovery compounds
Homepage
>
Company
>
Media
>
Pharma News
Pharma News
FDA approves Lilly’s Inluriyo
FDA approves Lilly’s Inluriyo to treat advanced breast cancer
Synaffix and Qurient
Synaffix and Qurient enter licensing deal for dual-payload ADC
Biotech Stocks Facing
Biotech Stocks Facing FDA Decision In October 2025
WSU study first
WSU study first to determine best method of preclinical testing for alcohol use disorder medications
Nightmare bacteria
«Nightmare bacteria» cases on the rise in the US: CDC
NRx Pharmaceuticals
NRx Pharmaceuticals Receives FDA Approval of Suitability Petition for Preservative-Free Ketamine Product
Akari Therapeutics
Akari Therapeutics’ Preclinical Data Demonstrates the Potential of its Novel ADC Spliceosome Modulating Payload, PH1
Breakthrough Therapy Designation To Povetacicept
Vertex: FDA Grants Breakthrough Therapy Designation To Povetacicept
IGC Pharma
IGC Pharma Announces Preclinical Data Demonstrating TGR-63’s Dual Action on Alzheimer’s Pathology
Autism Symptoms in Kids
FDA to Approve New Use of Cancer Drug for Autism Symptoms in Kids
Hanmi
Hanmi Reveals Promising Preclinical Results for Obesity Drug
Astellas’ Izervay
Astellas’ Izervay gains conditional approval in Japan for GA treatment
23
24
25
26
27
28
29
30
31
